Government News

​​​​The overall Indian pharmaceutical market grown around 12.1 percent by value and 4.8 percent by volume in month of August as per the market research firm AWACS.

Almost all the therapy areas have shown a robust double-digit growth or in case of units the growth may be single digit due to NLEM permission to hike price come into the picture and number of companies have shown a good price driven growth for the month of August.

From 2023, there will be no free COVID-19 vaccines for Americans. The US federal government may opt for full commercialization of COVID-19 vaccines and other oral antiviral medicines.

The US federal government has played the central coordinating role in buying, distributing, and ensuring equitable access to COVID-19 vaccines, therapeutics, and tests.

Union Minister of Chemical and Fertilizers, Dr. Mansukh Mandaviya urges pharma industries to produce medicines and bring innovative research with the goal of ensuring good health and well-being of the people, not only for commercial purpose.

Assam based Association of Advanced Pharmacy Practitioners (AAPP) decides that they will not participate in the forthcoming World Pharmacist Day celebration programme on 25th September as a mark of resentment over the issue of not maintaining uniform standard of national eligibility in Pharmacy admission procedure.

To commemorate 25 years of existence of National Pharmaceutical Pricing Authority (NPPA), a programme will be organised at the Dr. Ambedkar International Centre, Janpath. Union Minister for Chemicals & Fertilizers and Health & Family Welfare Dr. Mansukh Mandaviya will grace the occasion as Chief Guest. MoS for Chemicals & Fertilizers and New & Renewable Energy will grace the occasion as Guest of Honour.

Recently Government has revised guidelines for the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical devices.

Tamil Nadu All Registered Pharmacists Welfare Association requesting Pharmacy council of India to not conduct the exit examination for Pharmacists.

The General Secretary, of TNARPW association said that, we have received notification about exit exam for pharmacy students for upcoming November 2022. We are not happy by this announcement actually. Our association clearly stands with welfare of public at all the time. But we are expecting some response from PCI for our questions.

National Pharmaceutical Pricing Authority, NPPA has rejected the application of Intas Pharmaceuticals for exemption from the provisions of Drug Price Control Order, DPCO, 2013 under Para 32 (iii) for the formulations Clozapine Extended Release Capsules.

The expert committee of NPPA had received application from Intas Pharmaceuticals for exemption from the provisions of DPCO 2013 under para 32 (iii) for the formulations Clozapine extended release capsules 12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg.

The old Drugs and Cosmetics Act, 1940 is to be replaced by the New Drugs, Medical Devices and Cosmetics Bill, 2022. Ministry of Health and Family Welfare, Government of India proposes a draft New Drugs, Medical Devices and Cosmetics Bill, 2022 in order to keep pace with changing needs, times, technology.